Viloi IV infusion 100mg, manufactured by Astellas Pharma, contains Zolbetuximab (genetical recombination). This monoclonal antibody targets Claudin 18.2, a protein found on the surface of certain cancer cells, to induce direct tumor cell killing and antibody-dependent cellular cytotoxicity. It is supplied as 100mg per bottle, with YJ code 4291471D1021.
Viloi IV infusion 100mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
